Prime Medicine

Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The company leverages its proprietary Prime Editing platform, a versatile, precise, and efficient gene editing technology, to develop a new class of differentiated, one-time, potentially curative genetic therapies. Prime Medicine is progressing a diversified portfolio of investigational therapeutic programs organized around core areas of focus: hematology, immunology & oncology, liver, and lung.